ASX - By Stock
|
CYP |
Re:
Ann: Further GvHD Clinical Data Published in Nature Medicine
|
|
pfeifer1982
|
9 |
1.3K |
12 |
09:52 |
09:52 |
ASX - By Stock
|
9
|
1.3K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 3Y-Dr Geoffrey Brooke
|
|
pfeifer1982
|
41 |
6.4K |
7 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
41
|
6.4K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 3Y-Dr Geoffrey Brooke
|
|
pfeifer1982
|
41 |
6.4K |
7 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
41
|
6.4K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 3Y-Dr Geoffrey Brooke
|
|
pfeifer1982
|
41 |
6.4K |
11 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
41
|
6.4K
|
11
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 3Y-Dr Geoffrey Brooke
|
|
pfeifer1982
|
41 |
6.4K |
3 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
41
|
6.4K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in CHM 0201 Vactosertib trial
|
|
pfeifer1982
|
15 |
7.3K |
14 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
15
|
7.3K
|
14
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
pfeifer1982
|
71 |
11K |
11 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
71
|
11K
|
11
|
|
ASX - By Stock
|
CYP |
Re:
Ann: DFU Clinical Trial Enrolment Complete
|
|
pfeifer1982
|
22 |
5.8K |
10 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
22
|
5.8K
|
10
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
pfeifer1982
|
428 |
149K |
7 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
428
|
149K
|
7
|
|
ASX - By Stock
|
CYP Biotech |
Timelines
|
|
pfeifer1982
|
4 |
1.2K |
24 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
4
|
1.2K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
pfeifer1982
|
569 |
210K |
10 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
569
|
210K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
pfeifer1982
|
569 |
210K |
48 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
569
|
210K
|
48
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
pfeifer1982
|
61 |
11K |
14 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
61
|
11K
|
14
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
pfeifer1982
|
61 |
11K |
7 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
61
|
11K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
pfeifer1982
|
61 |
11K |
12 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
61
|
11K
|
12
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Clinical milestones for 2024 & 2023 successes highlighted
|
|
pfeifer1982
|
26 |
9.3K |
15 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
26
|
9.3K
|
15
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
pfeifer1982
|
19 |
3.2K |
10 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
19
|
3.2K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
pfeifer1982
|
2.1K |
683K |
8 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
2.1K
|
683K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
pfeifer1982
|
19 |
3.2K |
8 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
19
|
3.2K
|
8
|
|
ASX - By Stock
|
CYP |
The Phase I/IIb Nereid Study Is Now Registered
|
|
pfeifer1982
|
19 |
3.2K |
18 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
19
|
3.2K
|
18
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
pfeifer1982
|
61 |
11K |
10 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
61
|
11K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
pfeifer1982
|
21 |
5.5K |
19 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
21
|
5.5K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pfeifer1982
|
9.6K |
2.8M |
11 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
11
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
pfeifer1982
|
694 |
278K |
6 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
694
|
278K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pfeifer1982
|
9.6K |
2.8M |
13 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pfeifer1982
|
9.6K |
2.8M |
7 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Initial Results in First 16 DFU Patients Expected in Q1 2024
|
|
pfeifer1982
|
37 |
12K |
17 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
37
|
12K
|
17
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in CHM 0201 Vactosertib trial
|
|
pfeifer1982
|
15 |
7.3K |
5 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
15
|
7.3K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
pfeifer1982
|
75 |
22K |
12 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
75
|
22K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First USA site initiated in aGvHD trial
|
|
pfeifer1982
|
31 |
8.1K |
17 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
31
|
8.1K
|
17
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First USA site initiated in aGvHD trial
|
|
pfeifer1982
|
31 |
8.1K |
17 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
31
|
8.1K
|
17
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Phase 1B ADVENT-AML trial to be presented at ASH meeting
|
|
pfeifer1982
|
7 |
3.0K |
11 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
7
|
3.0K
|
11
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
pfeifer1982
|
394 |
84K |
20 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
394
|
84K
|
20
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 2 Trial of CYP-001 in aGvHD Approved in Turkey
|
|
pfeifer1982
|
9 |
2.7K |
18 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
9
|
2.7K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Information For Retail Shareholders
|
|
pfeifer1982
|
541 |
115K |
27 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
541
|
115K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pfeifer1982
|
9.6K |
2.8M |
7 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
9.6K
|
2.8M
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Cymerus MSCs for Neonatal Stroke
|
|
pfeifer1982
|
18 |
4.2K |
12 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
18
|
4.2K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 4E & Annual Report
|
|
pfeifer1982
|
15 |
5.6K |
9 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
15
|
5.6K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
pfeifer1982
|
904 |
277K |
12 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
904
|
277K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
pfeifer1982
|
904 |
277K |
19 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
904
|
277K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Why a trial?
|
|
pfeifer1982
|
107 |
34K |
4 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
107
|
34K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
pfeifer1982
|
1.3K |
549K |
7 |
12/08/23 |
12/08/23 |
ASX - By Stock
|
1.3K
|
549K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
pfeifer1982
|
1.3K |
549K |
4 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
1.3K
|
549K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
$200m MkCap / 30c
|
|
pfeifer1982
|
191 |
67K |
13 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
191
|
67K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
pfeifer1982
|
904 |
277K |
14 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
904
|
277K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
What Data is available from Japan?
|
|
pfeifer1982
|
41 |
11K |
17 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
41
|
11K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
What Data is available from Japan?
|
|
pfeifer1982
|
41 |
11K |
11 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
41
|
11K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
What Data is available from Japan?
|
|
pfeifer1982
|
41 |
11K |
10 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
41
|
11K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
What Data is available from Japan?
|
|
pfeifer1982
|
41 |
11K |
7 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
41
|
11K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
"Good vibes Here Dudes".....
|
|
pfeifer1982
|
44 |
15K |
13 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
44
|
15K
|
13
|
|